title: Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia.
authors.forename: Valentine
authors.initials: V
authors.lastname: Brousse
authors.forename: Shreyans
authors.initials: S
authors.lastname: Gandhi
authors.forename: Mariane
authors.initials: M
authors.lastname: de Montalembert
authors.forename: Sue
authors.initials: S
authors.lastname: Height
authors.forename: Moira C
authors.initials: MC
authors.lastname: Dick
authors.forename: Sandra
authors.initials: S
authors.lastname: O'Driscoll
authors.forename: Gaëlle
authors.initials: G
authors.lastname: Abihsera
authors.forename: David C
authors.initials: DC
authors.lastname: Rees
mesh_terms: D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D001803:Blood Transfusion; D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control; D002544:Cerebral Infarction / Q000209:etiology / Q000517:prevention & control; D002548:Cerebral Revascularization; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control / Q000601:surgery / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D007958:Leukocyte Count; D008297:Male; D009072:Moyamoya Disease / Q000209:etiology / Q000628:therapy; D012189:Retrospective Studies; D055502:Secondary Prevention; D065227:Transfusion Reaction
chemical_list: D006454:Hemoglobins; D006918:Hydroxyurea